US 8148340
Immunomodulatory oligonucleotides
granted A61KA61K2039/55561A61K31/4706
Quick answer
US patent 8148340 (Immunomodulatory oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/55561, A61K31/4706, A61K39/39